‌

Quick-Med Technologies, Inc. SBIR Phase I Award, December 2019

A SBIR Phase I contract was awarded to Quick-Med Technologies in December, 2019 for $49,982.0 USD from the U.S. Department of Defense and United States Air Force.

Overview Structured Data Issues Contributors

sbir.gov/node/1940661

Is a

SBIR/STTR Awards

SBIR/STTR Award attributes

SBIR/STTR Award Recipient

Quick-Med Technologies

Government Agency

U.S. Department of Defense

Government Branch

United States Air Force

Award Type

SBIR0

Contract Number (US Government)

FA8649-20-P-00400

Award Phase

Phase I0

Award Amount (USD)

49,9820

Date Awarded

December 12, 2019

End Date

December 12, 2020

Abstract

Quick-Med Technologies, Inc. (Gainesville, FL) is an innovative life sciences company specializing in the development of next-generation antimicrobial technologies for the healthcare, consumer, and Government markets. Quick-Med (QMT) has developed the world's most advanced antimicrobial technologies that combat microbial growth in a variety of broad-based products. Our technology is always designed to be safe for the environment and public health. By utilizing biomimetic chemistries, broad and long-lasting antimicrobial efficacy can be provided at affordable cost, without concern about bacterial resistance, or environmental toxicity.